Bionano Genomics, Inc. (BNGO)
1.48
-0.09
(-5.73%)
USD |
NASDAQ |
Oct 02, 16:00
1.49
+0.01
(+0.68%)
Pre-Market: 20:00
Bionano Genomics EPS Diluted (Quarterly) : -0.6429 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.6429 |
| March 31, 2026 | -0.7563 |
| December 31, 2025 | -0.7386 |
| September 30, 2025 | -1.593 |
| June 30, 2025 | -1.993 |
| March 31, 2025 | -1.151 |
| December 31, 2024 | -10.79 |
| September 30, 2024 | -0.5153 |
| June 30, 2024 | -0.2401 |
| March 31, 2024 | -0.5958 |
| December 31, 2023 | -0.9593 |
| September 30, 2023 | -3.216 |
| June 30, 2023 | -1.235 |
| March 31, 2023 | -1.229 |
| December 31, 2022 | -1.302 |
| September 30, 2022 | -1.098 |
| June 30, 2022 | -1.126 |
| March 31, 2022 | -1.052 |
| December 31, 2021 | -0.8136 |
| Date | Value |
|---|---|
| September 30, 2021 | -0.7407 |
| June 30, 2021 | -0.6736 |
| March 31, 2021 | -0.3769 |
| December 31, 2020 | -0.6175 |
| September 30, 2020 | -0.8118 |
| June 30, 2020 | -0.8882 |
| March 31, 2020 | -2.955 |
| December 31, 2019 | -2.305 |
| September 30, 2019 | -5.871 |
| June 30, 2019 | -7.058 |
| March 31, 2019 | -7.690 |
| December 31, 2018 | -6.376 |
| September 30, 2018 | -6.333 |
| June 30, 2018 | -3.313 |
| March 31, 2018 | -3.849 |
| September 30, 2017 | -305.27 |
| June 30, 2017 | -6.678 |
| March 31, 2017 | -5.688 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 1.279 |
| Bio-Rad Laboratories, Inc. | 13.85 |
| Bruker Corp. | -0.413 |
| Danaher Corp. | 1.230 |
| Harvard Bioscience, Inc. | -0.643 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -7.423M |
| Revenue (Quarterly) | 8.171M |
| Total Expenses (Quarterly) | 15.59M |
| Enterprise Value | 13.71M |
| Gross Profit Margin (Quarterly) | 52.80% |
| Profit Margin (Quarterly) | -90.85% |
| Earnings Yield | -252.1% |
| Normalized Earnings Yield | -244.70 |